Video: Dr. Eva Feldman discusses ALS on PBS "Second Opinion" program
Taubman Institute Director Eva Feldman, M.D., Ph.D. was among four panelists invited to discuss amyotrophic lateral sclerosis (ALS) on the nationally syndicated, award-winning PBS medical program "Second Opinion."
The program featured ALS patient Gary Tamoyen discussing the progression of his disease, as Dr. Feldman and other experts explained the procedures followed in diagnosing ALS and how the diseases progresses.
Click here to view the full episode.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars publish new findings on basal cell cancer
Ophthalmologists Alon Kahana, MD, PhD and Rajesh Rao, MD are trying to pinpoint when the common cancer turns dangerous.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results